Literature DB >> 3931058

Role of beta-lactamase-producing bacteria in the failure of penicillin to eradicate group A streptococci.

I Brook.   

Abstract

Ninety-eight children who had acute tonsillitis due to Group A beta-hemolytic streptococci were treated for 10 days with orally administered penicillin B, potassium. Surface tonsillar cultures were obtained before therapy, at the end of therapy and 10, 21 and 42 days after termination of therapy. The cultures obtained before and after completion of treatment were processed for aerobic and anaerobic organisms, while the other cultures were processed only for Group A beta-hemolytic streptococci. On the basis of bacteriologic results 62 patients were considered "cured" (Group A) and 36 "failed" (Group B) following therapy. Before therapy 18 isolates of beta-lactamase-producing organisms (BLPO) were detected in 16 (26%) children in Group A; after therapy 30 BLPO were detected in 19 (30%) children. In contrast, before therapy 40 BLPO were recovered from 25 (69%) children in Group B; this number increased to 62 BLPO in 31 (86%) of those children. The study demonstrates an association between failure to eradicate Group A beta-hemolytic streptococci and the presence of aerobic and anaerobic BLPO.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3931058     DOI: 10.1097/00006454-198509000-00010

Source DB:  PubMed          Journal:  Pediatr Infect Dis        ISSN: 0277-9730


  20 in total

Review 1.  Antibacterial therapy for acute group a streptococcal pharyngotonsillitis: short-course versus traditional 10-day oral regimens.

Authors:  Itzhak Brook
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

2.  Direct and indirect pathogenicity of beta-lactamase-producing bacteria in respiratory tract infection in children. Role of cephalosporins resistant to enzymatic hydrolysis.

Authors:  S Stefani; M B Pellegrino; G Russo; G Nicoletti
Journal:  Drugs       Date:  1991       Impact factor: 9.546

Review 3.  Optimum treatment of streptococcal pharyngitis.

Authors:  F Scaglione; G Demartini; M M Arcidiacono; J P Pintucci
Journal:  Drugs       Date:  1997-01       Impact factor: 9.546

4.  In vitro antimicrobial effects of various combinations of penicillin and clindamycin against four strains of Streptococcus pyogenes.

Authors:  D L Stevens; K J Madaras-Kelly; D M Richards
Journal:  Antimicrob Agents Chemother       Date:  1998-05       Impact factor: 5.191

5.  Penicillin failure in the treatment of streptococcal pharyngo-tonsillitis.

Authors:  Itzhak Brook
Journal:  Curr Infect Dis Rep       Date:  2013-06       Impact factor: 3.725

6.  Azithromycin versus cefaclor in the treatment of pediatric patients with acute group A beta-hemolytic streptococcal tonsillopharyngitis.

Authors:  J Cremer; C Wallrauch; D Milatovic; I Braveny
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-04       Impact factor: 3.267

7.  Evaluation of potential factors contributing to microbiological treatment failure in Streptococcus pyogenes pharyngitis.

Authors:  S M Kuhn; J Preiksaitis; G J Tyrrel; T Jadavji; D Church; H D Davies
Journal:  Can J Infect Dis       Date:  2001-01

8.  Ampicillin and ampicillin-sulbactam dilution tests with mixed cultures of Bacteroides fragilis, Escherichia coli and Enterococcus.

Authors:  F Heilmann
Journal:  Infection       Date:  1993 May-Jun       Impact factor: 3.553

9.  Efficacy of sulbactam in an in vitro model of mixed aerobic/anaerobic infections.

Authors:  W R Heizmann; F Heilmann; B Egeler; H Werner
Journal:  Infection       Date:  1990 Mar-Apr       Impact factor: 3.553

Review 10.  The role of beta-lactamase-producing-bacteria in mixed infections.

Authors:  Itzhak Brook
Journal:  BMC Infect Dis       Date:  2009-12-14       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.